AbbVie Inc. (ABBV)

ABBV

$294.97

per share, on-chain

What AbbVie Inc. (ABBV) does

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Industry: Healthcare
CEO: Robert A. Michael
Website: abbvie.com

Ways to own AbbVie Inc. (ABBV)

There's one version of this stock on Firstshare.

OndoABBVonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$294.97
Open, outside US hours

Price check

What a slice looks like

$10.00 buys you 0.034 of one AbbVie Inc. (ABBV) share.

That's 3.4% of one share. Small, but it's yours, and it moves with the real price. One share costs $294.97.